# CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients

> **NCT05482100** · — · NOT_YET_RECRUITING · sponsor: **Transplant Genomics, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **DIAGNOSTIC_TEST:** Patients monitored with OmniGraf testing

## Key facts

- **NCT ID:** NCT05482100
- **Lead sponsor:** Transplant Genomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-09
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05482100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05482100, "CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05482100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*